MSME (Udyam registered) Ministry of MSME
- Udyam number
- UDYAM-UK-05-0003747
Acies Pharmaceutical Private Limited - pharma in Dehradun, Uttarakhand, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹37.03 Cr
▲ 68% YoY
Net profit · FY 2025
₹2.57 Cr
Net margin 6.9%
EBITDA · FY 2025
₹3.86 Cr
EBITDA margin 10.4%
Authorised capital
₹1 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Open charges
₹10.39 Cr
Secured borrowings
Company age
7 yrs
Est. 2019
Directors on board
2
As per MCA filings
About Acies Pharmaceutical Private Limited
Data last updated:
Acies Pharmaceutical Private Limited is a private limited company based in Dehradun, Uttarakhand, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 19 April 2019 and has been in existence for over 7 years.
The company is registered with the Registrar of Companies (ROC), Uttarakhand, under CIN U74999UR2019PTC009735. Its GSTIN is 05AASCA1924E1ZV (Uttarakhand).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Bhasker Dabral and Sujata Dabral.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at First Floor 74/1 Nari Shilip Marg, Dehradun, Uttarakhand, India – 248001.
As per the financials filed for FY 2025, the company reported a revenue of ₹37.03 Cr, a growth of 68% compared to the previous year. For the same year it recorded a net profit of ₹2.57 Cr (net margin 6.9%) and EBITDA of ₹3.86 Cr (EBITDA margin 10.4%). Revenue has grown at a compounded annual rate (CAGR) of 36% over three years and 153% over five years.
The company is associated with 1 brand: Acies Pharmaceutical. As per MCA filings, the company has open charges of ₹10.39 Cr on record.
Acies Pharmaceutical Private Limited is registered as an MSME under the Udyam registration framework (Reg. No. UDYAM-UK-05-0003747). For more details, the company can be reached via its website aciespharmaceutical.com.
Company details
CIN U74999UR2019PTC009735
Registration Number 009735
Incorporation Date 19 April 2019
ROC Uttarakhand
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
MSME Classification MSME
Udyam Registration UDYAM-UK-05-0003747
Key People
Bhasker Dabral Director Sujata Dabral Director Recognitions & Rankings of Acies Pharmaceutical
Contact details
Acies Pharmaceutical Private Limited's registered office is in Dehradun, Uttarakhand. Its website is aciespharmaceutical.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Social Media
- Registered AddressFirst Floor 74/1 Nari Shilip Marg, Dehradun, Uttarakhand, India – 248001
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Acies Pharmaceutical Private Limited, buy the company report.
Comprehensive company report
Acies Pharmaceutical Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Brands
Acies Pharmaceutical operates one associated brand: Acies Pharmaceutical. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Manufacturing and exporting of pharmaceutical, nutraceutical, and ayurvedic products in India. | aciespharmaceutical.com |
Business activity
The main business activity of Acies Pharmaceutical is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Acies Pharmaceutical Private Limited, buy the company report.
Financials of Acies Pharmaceutical Private Limited
FY 2025 filings availableAcies Pharmaceutical Private Limited reported revenue of ₹37.03 Cr (up 68% YoY) for FY 2025.
Revenue · FY 2025
₹37.03 Cr ▲ 68%
Net profit · FY 2025
₹2.57 Cr margin 6.9%
EBITDA · FY 2025
₹3.86 Cr margin 10.4%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 68%
3 years · compounded
▲ 36%
5 years · compounded
▲ 153%
EBITDA CAGR growth
1 year
▲ 59%
3 years · compounded
▲ 55%
5 years · compounded
▲ 333%
Revenue has grown at a compounded annual rate (CAGR) of 153% over five years, including 68% growth in the latest year. EBITDA rose 59% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹3.86 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹2.57 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 10.4% | ||||
| Net Profit Margin | 6.9% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Acies Pharmaceutical Private Limited, buy the company report.
Board of directors of Acies Pharmaceutical Private Limited
Acies Pharmaceutical has 2 directors on record. No former directors are listed.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Bhasker Dabral Also directs: Alexon Healthcare Private Limited | Director | 19 Apr 2019 | 7 Years 6 Months | Current |
| Sujata Dabral Also directs: Alexon Healthcare Private Limited, Acies Lifesciences LLP | Director | 19 Apr 2019 | 7 Years 6 Months | Current |
Peer comparison
Acies Pharmaceutical Private Limited is compared with the 4 companies closest to it by revenue in the Pharma industry (Formulations), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Anhox Healthcare Private Limited | ₹37.41 Cr (FY 2025) | 12.0% | Ahmedabad, Gujarat, India | |||
| Alvio Pharmaceuticals Private Limited | ₹37.1 Cr (FY 2025) | 7.0% | Sarkhej, Gujarat, India | |||
| Shifa Remedies Private Limited | ₹37.06 Cr (FY 2025) | 6.0% | New Delhi, Delhi, India | |||
| Acies Pharmaceutical Private Limitedthis company | ₹37.03 Cr (FY 2025) | ₹2.57 Cr | 6.9% | 68.0% | Dehradun, Uttarakhand, India | |
| Prism Life Sciences Limited | ₹36.89 Cr (FY 2025) | -11.0% | Thane, Maharashtra, India |
To see the full peer comparison of Acies Pharmaceutical Private Limited, buy the company report.
Auditor
Acies Pharmaceutical Private Limited is audited by N KUMAR GUPTA & ASSOCIATES for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| N KUMAR GUPTA & ASSOCIATES | FY 2023 | 003637C |
Shareholding
The shareholding of Acies Pharmaceutical Private Limited is on record for 4 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|
| Promoters | ||||
| Domestic institutional investors (DII) | ||||
| Foreign institutional investors (FII) | ||||
| Public | ||||
| Others |
To see the full shareholding pattern of Acies Pharmaceutical Private Limited, buy the company report.
Charges & borrowings
Open charges
₹10.39 Cr
Satisfied charges
None
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 27 May 2025 | 101100014 | Others | ₹5.39 Cr | Open | |
| 24 Jan 2024 | 100880730 | Axis Bank Limited | ₹3.6 Cr | Open | |
| 29 Jan 2022 | 100540219 | Others | ₹1.4 Cr | Open |
To see the full charge records of Acies Pharmaceutical Private Limited, buy the company report.
Total charge records: 3 View all charges
Legal cases
No court or tribunal cases involving Acies Pharmaceutical Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Acies Pharmaceutical Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Acies Pharmaceutical has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 05AASCA1924E1ZV | Uttarakhand | Active | 07 May 2019 |
To see the full GST registrations and return filing status of Acies Pharmaceutical Private Limited, buy the company report.
Recent activity
Acies Pharmaceutical Private Limited has 2 board changes on record since 2019: 2 appointments. The latest: Bhasker Dabral was appointed as Director on 19 Apr 2019.
AGM
Acies Pharmaceutical Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Charges
A charge with Others amounted to Rs. 539.00 Lakh with Charge ID 101100014 was registered on 27 May 2025.
Filing
Acies Pharmaceutical Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Uttarakhand.
Charges
A charge with Axis Bank Limited amounted to Rs. 360.00 Lakh with Charge ID 100880730 was registered on 24 Jan 2024.
Charges
A charge with Others of Rs. 140.00 Lakh registered on 29 Jan 2022 with Charge ID 100540219 was modified on 25 May 2023.
Charges
A charge with Others amounted to Rs. 140.00 Lakh with Charge ID 100540219 was registered on 29 Jan 2022.
Appointed
Bhasker Dabral was appointed as Director.
Appointed
Sujata Dabral was appointed as Director.
Incorporation
19 Apr 2019
Acies Pharmaceutical Private Limited was registered on 19 Apr 2019 with Roc Uttarakhand & aged 7 years 6 months as per MCA records.
Frequently asked questions
Acies Pharmaceutical is an active private limited company based in Dehradun, Uttarakhand, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 19 April 2019 (7+ years old) and is registered under CIN U74999UR2019PTC009735.
Acies Pharmaceutical has 2 current directors:
- Bhasker Dabral - Director
- Sujata Dabral - Director
The latest financial statements of Acies Pharmaceutical on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2020 are in the company report.
The GSTIN of Acies Pharmaceutical is 05AASCA1924E1ZV, registered in Uttarakhand.
The CIN (Corporate Identification Number) of Acies Pharmaceutical is U74999UR2019PTC009735. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Acies Pharmaceutical was incorporated on 19 April 2019, making it 7+ years old. It is registered with the Registrar of Companies, Uttarakhand.
The peers of Acies Pharmaceutical by revenue are Anhox Healthcare Private Limited, Alvio Pharmaceuticals Private Limited, Shifa Remedies Private Limited, Prism Life Sciences Limited, all in the Pharma industry (Formulations), with the same principal business activity (wholesale trading).
Bhasker Dabral was appointed as Director on 19 Apr 2019. Sujata Dabral was appointed as Director on 19 Apr 2019.
Yes, Acies Pharmaceutical is registered as an MSME under Udyam registration (number: UDYAM-UK-05-0003747).
Acies Pharmaceutical can be reached through the website aciespharmaceutical.com. Its registered office is in Dehradun, Uttarakhand, India.
The registered office of Acies Pharmaceutical is at First Floor 741 Nari Shilip Marg, Dehradun, Uttarakhand, India – 248001.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages